This HTML5 document contains 50 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n16http://linked.opendata.cz/resource/domain/vavai/projekt/
n15http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n13http://linked.opendata.cz/ontology/domain/vavai/
n11http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61388963%3A_____%2F08%3A00314920%21RIV09-AV0-61388963/
n4http://linked.opendata.cz/resource/domain/vavai/zamer/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n14http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n18http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n17http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n9http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n10http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61388963%3A_____%2F08%3A00314920%21RIV09-AV0-61388963
rdf:type
skos:Concept n13:Vysledek
dcterms:description
Adefovir (9-(2-phosphonomethoxyethyl)adenine) is an acyclic nucleoside phosphonate currently used for the treatment of hepatitis B. The aim of this study was to evaluate the effect of permeation enhancer DDAK (6-dimethylaminohaxanoic acid dodecyl ester) on the transdermal and topical delivery of adefovir. Adefovir (9-(2-fosfonomethoxyethyl)adenin) je acyklický fosfonát nukleosidu užívaný v praxi pro léčbu hetatitidy B. Cílem této studie bylo stanovení vlivu aktivátoru průniku DDAK (dodecyl ester 6-dimethylaminohexanové kyseliny) na transdermální a topickou aplikaci adefoviru. Adefovir (9-(2-phosphonomethoxyethyl)adenine) is an acyclic nucleoside phosphonate currently used for the treatment of hepatitis B. The aim of this study was to evaluate the effect of permeation enhancer DDAK (6-dimethylaminohaxanoic acid dodecyl ester) on the transdermal and topical delivery of adefovir.
dcterms:title
Permeation enhancer dedocyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: Influence of pH, ion-pairing and skin species Permeation enhancer dedocyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: Influence of pH, ion-pairing and skin species Aktivátor průniku dodecycl 6-(dimethylamino)hexanoát zlepšuje transdermální a topickou aplikaci adefoviru: Vliv pH, párování iontů a druhu kůže
skos:prefLabel
Permeation enhancer dedocyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: Influence of pH, ion-pairing and skin species Permeation enhancer dedocyl 6-(dimethylamino)hexanoate increases transdermal and topical delivery of adefovir: Influence of pH, ion-pairing and skin species Aktivátor průniku dodecycl 6-(dimethylamino)hexanoát zlepšuje transdermální a topickou aplikaci adefoviru: Vliv pH, párování iontů a druhu kůže
skos:notation
RIV/61388963:_____/08:00314920!RIV09-AV0-61388963
n3:aktivita
n6:S n6:P n6:Z
n3:aktivity
P(1M0508), S, Z(AV0Z40550506), Z(MSM0021620822)
n3:cisloPeriodika
3
n3:dodaniDat
n10:2009
n3:domaciTvurceVysledku
n15:9587217
n3:druhVysledku
n9:J
n3:duvernostUdaju
n12:S
n3:entitaPredkladatele
n11:predkladatel
n3:idSjednocenehoVysledku
386302
n3:idVysledku
RIV/61388963:_____/08:00314920
n3:jazykVysledku
n18:eng
n3:klicovaSlova
adefovir; acyclic nucleoside phosphonates; antiviral; transdermal drug delivery; permeation enhancer
n3:klicoveSlovo
n14:antiviral n14:permeation%20enhancer n14:acyclic%20nucleoside%20phosphonates n14:adefovir n14:transdermal%20drug%20delivery
n3:kodStatuVydavatele
NL - Nizozemsko
n3:kontrolniKodProRIV
[BE3670DACAF7]
n3:nazevZdroje
European Journal of Pharmaceutics and Biopharmaceutics
n3:obor
n17:CC
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
5
n3:projekt
n16:1M0508
n3:rokUplatneniVysledku
n10:2008
n3:svazekPeriodika
70
n3:tvurceVysledku
Lorencová, K. Novotný, J. Vávrová, K. Holý, Antonín Hrabálek, A.
n3:wos
000261484300028
n3:zamer
n4:AV0Z40550506 n4:MSM0021620822
s:issn
0939-6411
s:numberOfPages
7